In this manuscript, the authors reported that the linear ubiquitin chain assembly complex (LUBAC) ubiquitinates STAT1 in resting cells. Linear ubiquitination of STAT1 blocks the recruitment of STAT1 to IFNAR2 and subsequent phosphorylation by JAK1. Upon IFN-IFNAR2 engagement, OTULIN removes the linear ubiquitination of STAT1 to promote its activation. Furthermore, prototype RNA viruses (Sendai virus and VSV) can induce the expression of HOIP to promote the linear ubiquitination of STAT1. Overall, this discovery is very interesting and informative in the regulation of STAT-mediated immune response. However, there are a few questions that the authors may address.
Major issues: 1. Scientifically, the manuscript is very solid and findings are supported by extensive experiments. Regarding the implication of linear ubiquitination of STAT1 in viral immune evasion, their findings did not support the conclusion. In order to support the author's conclusion, one may have to show that viruses, such as SeV and VSV, deploy specific strategies to induce this activity. Rather, it is conceivable that the virus-induced linear ubiquitination of STAT1 is a negative feedback mechanism that cells developed to avoid overt inflammation and subsequent collateral damage. 2. IFNγ, in addition to type I interferons, can induce STAT1 phosphorylation at Tyr701 that drives the homodimerization of STAT1. In the nucleus, STAT1 homodimers bind to GAS elements and promote ISG transcription. It will be interesting and meaningful to detect whether linear ubiquitination can block the activation of STAT1 in type II interferon signaling.
Minor issues: 1. Many co-IP experiments do not have input, including those shown in Figure 1d , 1g, 3f, 5e, 6e, 6f, 6g, 6h, etc. 2. When detecting the phosphorylation of STAT1, the levels of total STAT1 should also be showed. 3. In Figure 4a and 4b, the protein levels of JAK1 and STAT1 should be showed in input. 4. In Figure 4d , the protein levels of STAT1 and IFNAR2 should be showed in input. 5. In general, the manuscript is well-written. However, I would recommend proof-reading by a professional or native English-speaking individual. Some examples from the manuscript: Study the effect…to a large extent… the sentence in line 194-195… Line 215-216,… in conjugation with (line 217)(In conjunction with?)… Reviewer #2 (Remarks to the Author):
In the manuscript by Zuo et al, the authors demonstrate a novel biochemical mechanism that negatively regulates STAT1 antiviral activity. Using extensive biochemical and genetic tools, the authors demonstrate that STAT1 is linearly ubiquitinated on at least two lysine residues by LUBAC. The linear ub of STAT1 inhibits its ability to signal by IFN-alpha, an antiviral cytokine. As a part of the mechanism, the linear ub of STAT1 prevents its interaction with IFNAR2 to inhibit IFN signaling. Furthermore, the authors also report that the deubiquitinase, Otulin removes the linear ub chains from STAT1 to restore the IFN signaling. Finally, the authors utilize Hoil-1+/-mice to study the biological significance of their study, and these mice exhibit reduced viral replication presumably due to the enhanced IFN-STAT1 signaling.
The study is very interesting, and using highly sophisticated biochemical approaches, the authors clearly established a novel posttranslational modification on STAT1 to regulate the IFN signaling. IFN is an antiviral cytokine; however, excessive IFN signaling can lead to undesired outcomes including autoimmune reactions and diseased states. Therefore, this study uncovers a new mechanism that may help develop new therapy based on the linearly ubiquitinated STAT1.
Dear reviewers,
Thank you so much for your very valuable comments, which are very helpful for us to improve our study. Here, we have addressed all concerns from two reviewers by carrying out a series of experiments and modifying this manuscript according to the reviewers' suggestions.
Again, I greatly appreciate! Best wishes,
Hui

Reviewers' comments
Reviewer #1 (Remarks to the Author):
Thank you so much for these good comments! Major issues: 1. Scientifically, the manuscript is very solid and findings are supported by extensive experiments. Regarding the implication of linear ubiquitination of STAT1 in viral immune evasion, their findings did not support the conclusion. In order to support the author's conclusion, one may have to show that viruses, such as SeV and VSV, deploy specific strategies to induce this activity. Rather, it is conceivable that the virus-induced linear ubiquitination of STAT1 is a negative feedback mechanism that cells developed to avoid overt inflammation and subsequent collateral damage.
This is a very good comment! We absolutely agree with the reviewer about the difference between viral evasion and host negative feedback.
Thus, we corrected our description and conclusion in the "viral evasion" section to reflect the actual negative feedback mechanism of STAT1 linear ubiquitination induced by viral infection. Please see Line 306-335.
In addition, to better demonstrate the negative feedback mechanism, 
IFNγ, in addition to type I interferons, can induce STAT1 phosphorylation at
Tyr701 that drives the homodimerization of STAT1. In the nucleus, STAT1 homodimers bind to GAS elements and promote ISG transcription. It will be interesting and meaningful to detect whether linear ubiquitination can block the activation of STAT1 in type II interferon signaling. Figure   1d, 1g, 3f, 5e, 6e, 6f, 6g, 6h, Fig. 1d, 1g, 3e, 5b, 5e, 6e, 6f, 6g, 6h , S1c, S4c, S5c, S5h, S6b, and S6d.
When detecting the phosphorylation of STAT1, the levels of total STAT1
should also be showed.
We have added the total STAT1 levels in the new Fig. 2c-e, 5i, 6k, 7b, S2c, S3d, S4a and S5i. Figure 4a and 4b, the protein levels of JAK1 and STAT1 should be showed in input.
In
We have added the protein levels of JAK1 and STAT1 as the input in Fig.   4a and 4b. Figure 4d , the protein levels of STAT1 and IFNAR2 should be showed in input.
Thanks! We have added the protein levels of STAT1 and IFNAR2 as the input in Fig. 4d . 
In general
Reviewer #2 (Remarks to the Author):
The study is very interesting, and using highly sophisticated biochemical approaches, the authors clearly established a novel posttranslational modification on STAT1 to regulate the IFN signaling. IFN is an antiviral cytokine; however, excessive IFN signaling can lead to undesired outcomes including autoimmune reactions and diseased states. Therefore, this study uncovers a new mechanism that may help develop new therapy based on the linearly ubiquitinated STAT1. Although the mechanistic part of the study is quite solid, the in vivo studies are relatively weaker. The authors should consider the following points to improve their study:
Thank you so much for these good comments! 1. The lack of a STAT1 knock-in mouse harboring mutated lysines does not allow the authors to directly test the new mechanism on the biological functions of IFN. Therefore, the phenotype in Hoil-1+/-mice may not be completely due to this new mechanism. The authors should find a way to establish this in vivo to significantly strengthen their study. Is it possible to address this partly ex vivo in the KO cells, by Fig. 8a, 8b, 8c. In addition, according to the reviewer's good suggestion, we got MEF cells from the Hoil-1l +/+ and Hoil-1l +/mice, and then these cells were transfected with STAT1-WT or STAT1-K511/652R mutants (DM), followed by mIFNβ treatment. The results showed that although mutation of Fig 3F. These results directly test the functional contribution of STAT1 linear ub, and should be moved to the main figure. This is a good suggestion! We re-designed this experiment and used IFNs to treat U3A (STAT1-deficient) cells that were transfected with STAT1 (WT or lysine mutants, DM), and then analyzed the antiviral functions of both STAT1-WT and STAT1-DM (Fig. S3i) .
The antiviral functions of the lysine mutants should be tested in the context of IFN-treated cells in Suppl
Also, we carried out the similar experiment in Stat1 -/mouse cells (see the following comment -comment 3 of the reviewer). The results confirmed that STAT1-Lys511/652 mutants mediate stronger IFN antiviral activity. According to the reviewer's suggestion, we have moved the data to the main figure. Please see the new Fig. 3k.   3 . Also, the antiviral functions should be tested in STAT1-/-mouse cells expressing the STAT1 mutants, to generalize the effects.
Please see the above experiments. We tested the antiviral functions in
Stat1 -/mouse cells expressing STAT1-WT or STAT1 Lys511/652 mutants, and moved the data to the main figure.
Virus infection induces IFN-beta in all cell types whereas IFN-alpha
expression is restricted primarily to the myeloid cells. It would be relevant to also show that the new mechanism is valid in IFN-beta treated cells as well to broaden the significance of the study.
Thanks! According to the reviewer's good suggestion, we carried out a series of experiments to observe the linear ubiquitination regulation of IFN-β antiviral response. Please see the new Fig. 2g, 2h, 5b and Fig. S2b,   S3g .
Many viruses (including SeV) inhibit phosphorylation of STAT1 and,
therefore, it would be interesting to see whether an unphosphorylated STAT1 mutant can undergo the new regulation. This is to support the claim that viruses may use this mechanism to evade IFN responses, as well as the transcriptional functions of unphosphorylated STAT1. This is a good suggestion! We actually have shown that an unphosphorylated STAT1 mutant (STAT1-Y701F) undergoes comparable levels of linear ubiquitination modifications with STAT1-WT in cells (Fig.   S4c ). To better address the reviewer's comment, here we further performed several experiments. We noticed that viral infection can also upregulate linear ubiquitination of STAT1-Y701F (new Fig. S6e) 
